← FDA Drug Approvals (Drugs@FDA)
FENTANYL CITRATE
NDA · New Drug Application · Sponsor: EXELA PHARMA · Approved 2023-02-08
Drug application
- FDA Application #
NDA215870- Application type
- New Drug Application
- Brand name
- FENTANYL CITRATE
- Generic name
- Fentanyl Citrate
- Active ingredients
- FENTANYL CITRATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- EXELA PHARMA
- First approval
- 2023-02-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown